Tumor sphere assays evaluation revealed the remarkable reduction the sphere-forming ability of CD44( + )-OSCC cells following METTL3 knockdown, which could be partially reversed it by SALL4 overexpression (Fig. 5A, B). This evidence concerns the gene METTL3 and neoplasm.